Microfluidics at the Forefront: Revolutionizing Biomedical Diagnostics

EasyChair Preprint 11552

Abstract

Microfluidics has emerged as a transformative technology in the realm of biomedical diagnostics, offering unparalleled opportunities to revolutionize the field. This paper aims to provide an overview of the significant advancements and potential applications of microfluidic systems in the context of biomedical diagnostics. The unique properties of microfluidic platforms, characterized by their ability to manipulate minute volumes of fluids within microscale channels, have enabled the development of highly sensitive, rapid, and cost-effective diagnostic tools. These devices leverage principles of physics, chemistry, and engineering to perform a myriad of functions, from sample preparation and analysis to disease detection and monitoring. This review explores the diverse array of microfluidic-based diagnostic modalities, including but not limited to point-of-care devices, lab-on-a-chip systems, organ-on-a-chip models, and droplet-based assays. These platforms have demonstrated exceptional capabilities in detecting various biomarkers, pathogens, and disease indicators with unprecedented sensitivity and specificity. However, challenges persist in the widespread adoption of microfluidic diagnostics, including standardization, scalability, and commercialization hurdles. Addressing these obstacles will be pivotal in transitioning these innovative technologies from research laboratories to clinical settings, thereby impacting healthcare delivery on a global scale.

Keyphrases: Biomedical diagnostics, Microfluidics, Point-of-care testing

@booklet{EasyChair:11552,
  author    = {Lee Kasowaki and Aydin Dogan},
  title     = {Microfluidics at the Forefront: Revolutionizing Biomedical Diagnostics},
  howpublished = {EasyChair Preprint 11552},
  year      = {EasyChair, 2023}}